Antioxidants inhibit neuronal toxicity in Parkinson's disease‐linked <scp>LRRK</scp>2
Dario C. Angeles(Singapore General Hospital), Eng‐King Tan(SingHealth), Patrick Ho(National Neuroscience Institute), Zhidong Zhou(Duke-NUS Medical School), Brian Dymock(National University of Singapore), Kah‐Leong Lim(Nanyang Technological University)
Cited by 39
Related Papers
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
|Movement Disorders|2023|351
Role of dopamine in the pathophysiology of Parkinson’s disease
|Translational Neurodegeneration|2023|253
SEPA-1 Mediates the Specific Recognition and Degradation of P Granule Components by Autophagy in C. elegans
|Cell|2009|236
Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases
|Molecular Neurodegeneration|2017|222
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function
|Human Molecular Genetics|2005|209